A fixed, low dose of anti-CD20 antibody (Rituximab) is an effective treatment for patients with chronic immune thrombocytopenia

被引：0
|
作者：
El-Najjar, I [1 ]
Rule, SAJ [1 ]
Nokes, TJC [1 ]
机构：
[1] Derriford Hosp, Dept Haematol, Plymouth PL6 8DH, Devon, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2006年 / 133卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：79 / 80
页数：2
相关论文
共 50 条
  • [41] Low-dose rituximab treatment in chinese patients with immune thrombocytopenia
    Wang, H-M
    Sui, T.
    Yang, Y.
    Zhou, Z.
    Liu, X.
    Liu, Y.
    Zhang, L.
    Yang, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 330 - 330
  • [42] Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma
    Giovanni Antonini
    Maria Cristina Cox
    Enrico Montefusco
    Antonella Ferrari
    Esmeralda Conte
    Stefania Morino
    Pamela Latino
    Guido Trasimeni
    Bruno Monarca
    Journal of Neuro-Oncology, 2007, 81 : 197 - 199
  • [43] Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma
    Antonini, Giovanni
    Cox, Maria Cristina
    Montefusco, Enrico
    Ferrari, Antonella
    Conte, Esmeralda
    Morino, Stefania
    Latino, Pamela
    Trasimeni, Guido
    Monarca, Bruno
    JOURNAL OF NEURO-ONCOLOGY, 2007, 81 (02) : 197 - 199
  • [44] Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab—monitoring of antiphospholipid and anti-GP antibodies: a case report
    R. Trappe
    A. Loew
    P. Thuss-Patience
    B. Dörken
    H. Riess
    Annals of Hematology, 2006, 85 : 134 - 135
  • [45] Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome
    Heelan, BT
    Tormey, V
    Amlot, P
    Payne, E
    Mehta, A
    Webster, ADB
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (04) : 1078 - 1081
  • [46] Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
    Mitchell R Smith
    Oncogene, 2003, 22 : 7359 - 7368
  • [47] The use of rituximab, anti-CD20 monoclonal antibody, in pediatric transplantation
    Pescovitz, MD
    PEDIATRIC TRANSPLANTATION, 2004, 8 (01) : 9 - 21
  • [48] Rituximab, an anti-CD20 monoclonal antibody: History and mechanism of action
    Pescovitz, MD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) : 859 - 866
  • [49] The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A
    D'Arena, Giovanni
    Grandone, Elvira
    Di Minno, Matteo N. D.
    Musto, Pellegrino
    Di Minno, Giovanni
    BLOOD TRANSFUSION, 2016, 14 (03) : 255 - 261
  • [50] Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
    Smith, MR
    ONCOGENE, 2003, 22 (47) : 7359 - 7368
12345